These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5697745)

  • 21. Immunosuppression versus immunity in syngeneic and allogeneic tumours.
    Vlachov K; Nouza K
    Neoplasma; 1973; 20(1):3-12. PubMed ID: 4573871
    [No Abstract]   [Full Text] [Related]  

  • 22. [Autoimmunity of experimental animals with induced carcinoma. 1. Autotransplantability of rats with methylcholanthrene-induced sarcoma].
    Takeda K; Aizawa M; Tsuji Y; Yamawaki S; Nakamura K
    Saishin Igaku; 1965 Oct; 20(10):2826-35. PubMed ID: 5886833
    [No Abstract]   [Full Text] [Related]  

  • 23. [Transplantation immunity to a UV-induced murine sarcoma by injection of a glycoprotein fraction from the tumor].
    Pasternak L; Ristau E
    Arch Geschwulstforsch; 1985; 55(1):17-21. PubMed ID: 3985765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.
    Currie GA; Bagshawe KD
    Br J Cancer; 1969 Mar; 23(1):141-9. PubMed ID: 5768430
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM
    Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of artificial metastases of methylcholanthrene-induced rat sarcomas by autoimmunization of the autochthonous hosts.
    Takeda K; Kikuchi Y; Yamawaki S; Ueda T; Yoshiki T
    Cancer Res; 1968 Oct; 28(10):2149-54. PubMed ID: 5696943
    [No Abstract]   [Full Text] [Related]  

  • 27. A preliminary investigation into the role of immunity in modifying the blood- borne spread of chemically induced rat sarcomas.
    Proctor JW; Rudenstam CM; Alexander P
    J Natl Cancer Inst; 1974 Dec; 53(6):1671-6. PubMed ID: 4373575
    [No Abstract]   [Full Text] [Related]  

  • 28. RNA-mediated transfer of tumor immunity--a new model for the immunotherapy of cancer.
    Deckers PJ; Pilch YH
    Cancer; 1971 Nov; 28(5):1219-28. PubMed ID: 5125669
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of the graft-versus-host reaction on transplantation immunity to homologous tumors].
    Semenkov VF; Shevelev AS
    Vopr Onkol; 1971; 17(6):69-73. PubMed ID: 4400328
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunogenetic study of tumor growth in inbred rats].
    Urizar LA; Ballina JC; Amerio N; Morini JC; Rabasa SL
    Medicina (B Aires); 1982; 42(4):403-8. PubMed ID: 15171022
    [No Abstract]   [Full Text] [Related]  

  • 31. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 32. Electrocoagulation vs excision: comparison of degree of immunity engendered by treatment of induced tumors in syngeneic mice.
    Sobel SH; Patterson WB
    Surg Forum; 1972; 23(0):85-7. PubMed ID: 4671034
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of aprotinin on the grafting of methylcholanthrene-induced sarcoma in rats].
    Laurentaci G; Dioguardi D; Pascone M
    Arch Sci Med (Torino); 1977; 134(3):283-92. PubMed ID: 304713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
    Kitano M; Okada Y; Nagaishi C
    Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the kinetics of transplantation immunity.
    Phillips ME
    Cancer Res; 1966 Jan; 26(1):40-7. PubMed ID: 5322597
    [No Abstract]   [Full Text] [Related]  

  • 36. Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system.
    Skurzak HM; Klein E; Yoshida TO; Lamon EW
    J Exp Med; 1972 Apr; 135(4):997-1002. PubMed ID: 5018057
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mechanisms of experimental hematogenous metastasis and its dependence on the reactive defense in the host organism].
    Arnold W; Graffi A
    Z Exp Chir; 1974; 7(4):216-27. PubMed ID: 4440031
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immune status during the combined use of microwave hyperthermia and prospidin in animals with transplantable tumors].
    Davydov VF; Iakhontov NE; Pugachev VF; Monakhov AA; Kuzin VB
    Med Radiol (Mosk); 1987 Oct; 32(10):56-8. PubMed ID: 3657439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The yeast Saccharomyces cerevisiae can become an immunity factor and inhibit graft of Sartorelli ascitic sarcoma TG 180 in mice].
    Vermeil C; Morin O
    C R Acad Hebd Seances Acad Sci D; 1970 Jul; 271(3):378-80. PubMed ID: 4988833
    [No Abstract]   [Full Text] [Related]  

  • 40. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM; Millar RC; Ketcham AS
    Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.